BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 24923734)

  • 21. Influence of chlorine or fluorine substitution on the estrogenic properties of 1-alkyl-2,3,5-tris(4-hydroxyphenyl)-1H-pyrroles.
    Schäfer A; Wellner A; Strauss M; Schäfer A; Wolber G; Gust R
    J Med Chem; 2012 Nov; 55(22):9607-18. PubMed ID: 23043242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
    Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
    Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
    Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F
    Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β.
    Galea GL; Meakin LB; Sugiyama T; Zebda N; Sunters A; Taipaleenmaki H; Stein GS; van Wijnen AJ; Lanyon LE; Price JS
    J Biol Chem; 2013 Mar; 288(13):9035-48. PubMed ID: 23362266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio.
    Sotoca AM; Ratman D; van der Saag P; Ström A; Gustafsson JA; Vervoort J; Rietjens IM; Murk AJ
    J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):171-8. PubMed ID: 18955141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERβ-specific agonists and genistein inhibit proliferation and induce apoptosis in the large and small intestine.
    Schleipen B; Hertrampf T; Fritzemeier KH; Kluxen FM; Lorenz A; Molzberger A; Velders M; Diel P
    Carcinogenesis; 2011 Nov; 32(11):1675-83. PubMed ID: 21856997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous estrogen receptor beta is transcriptionally active in primary ovarian cells from estrogen receptor knockout mice.
    Mueller SO; Katzenellenbogen JA; Korach KS
    Steroids; 2004 Sep; 69(10):681-6. PubMed ID: 15465114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
    Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
    Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen.
    Wu X; Subramaniam M; Grygo SB; Sun Z; Negron V; Lingle WL; Goetz MP; Ingle JN; Spelsberg TC; Hawse JR
    Breast Cancer Res; 2011 Mar; 13(2):R27. PubMed ID: 21392396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes.
    Nadal-Serrano M; Pons DG; Sastre-Serra J; Blanquer-Rosselló Mdel M; Roca P; Oliver J
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2045-51. PubMed ID: 23871935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
    Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
    J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
    Teng J; Wang ZY; Jarrard DF; Bjorling DE
    Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands.
    Shanle EK; Hawse JR; Xu W
    Biochem Pharmacol; 2011 Dec; 82(12):1940-9. PubMed ID: 21924251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of genistein as a selective estrogen receptor beta agonist on the expression of Calbindin-D9k in the uterus of immature rats.
    Lee GS; Choi KC; Kim HJ; Jeung EB
    Toxicol Sci; 2004 Dec; 82(2):451-7. PubMed ID: 15456916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.
    Sundar SN; Marconett CN; Doan VB; Willoughby JA; Firestone GL
    Carcinogenesis; 2008 Dec; 29(12):2252-8. PubMed ID: 18784357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine-Disrupting Chemicals (EDCs): In Vitro Mechanism of Estrogenic Activation and Differential Effects on ER Target Genes.
    Li Y; Luh CJ; Burns KA; Arao Y; Jiang Z; Teng CT; Tice RR; Korach KS
    Environ Health Perspect; 2013 Apr; 121(4):459-66. PubMed ID: 23384675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.
    Paterni I; Granchi C; Katzenellenbogen JA; Minutolo F
    Steroids; 2014 Nov; 90():13-29. PubMed ID: 24971815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines.
    Baker R; Dell'Acqua G; Richards A; Thornton MJ
    PLoS One; 2024; 19(2):e0297080. PubMed ID: 38408073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.